Croissance Board of Directors
Get the latest insights into the leadership at Croissance. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Sravan Prabhakar Veledandi | Managing Director |
| Mr. Amaresh Rao Gaikwad | Whole Time Director |
| Mr. Hriday Bahri | Non Executive Director |
| Mr. Hemant Bahri | Director |
| Mr. M Sridhar | Independent Director |
| Ms. Sowmya Ranganath | Independent Director |
Croissance Share price
CROISSANCE
2.7
0.09 (3.45%)Last updated on 4 Sep, 2025 | 15:28 IST
BUYSELL
Today's High
2.85
Today's Low
2.51
52 Week Low
2.21
52 Week High
4.60
The current prices are delayed, login to your account for live prices
LoginCroissance FAQs
The board at Croissance consists of experienced professionals, including Mr. Sravan Prabhakar Veledandi , Mr. Amaresh Rao Gaikwad , and others, overseeing the company’s strategic and corporate governance.
Directors at Croissance are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Sravan Prabhakar Veledandi is the current chairman at Croissance.
Executive directors at Croissance are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Croissance adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Croissance, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.